- Home
- CSW vs SLNO Comparison
CSW vs SLNO Comparison
Compare CSW & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSW
- SLNO
- Stock Information
- Founded
- CSW 2014
- SLNO 1999
- Country
- CSW United States
- SLNO United States
- Employees
- CSW N/A
- SLNO N/A
- Industry
- CSW Home Furnishings
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CSW Industrials
- SLNO Health Care
- Exchange
- CSW Nasdaq
- SLNO Nasdaq
- Market Cap
- CSW 4.4B
- SLNO 3.8B
- IPO Year
- CSW N/A
- SLNO 2014
- Fundamental
- Price
- CSW $249.70
- SLNO $59.21
- Analyst Decision
- CSW Hold
- SLNO Strong Buy
- Analyst Count
- CSW 3
- SLNO 9
- Target Price
- CSW $282.67
- SLNO $116.78
- AVG Volume (30 Days)
- CSW 147.7K
- SLNO 2.7M
- Earning Date
- CSW 10-29-2025
- SLNO 11-05-2025
- Dividend Yield
- CSW 0.43%
- SLNO N/A
- EPS Growth
- CSW 19.18
- SLNO N/A
- EPS
- CSW 8.37
- SLNO N/A
- Revenue
- CSW $915,770,000.00
- SLNO $32,656,999.00
- Revenue This Year
- CSW $21.71
- SLNO N/A
- Revenue Next Year
- CSW $8.89
- SLNO $181.85
- P/E Ratio
- CSW $29.85
- SLNO N/A
- Revenue Growth
- CSW 12.27
- SLNO N/A
- 52 Week Low
- CSW $238.49
- SLNO $41.50
- 52 Week High
- CSW $436.50
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CSW 46.00
- SLNO 44.37
- Support Level
- CSW $238.49
- SLNO $55.78
- Resistance Level
- CSW $260.79
- SLNO $68.46
- Average True Range (ATR)
- CSW 7.96
- SLNO 4.08
- MACD
- CSW 0.96
- SLNO 0.84
- Stochastic Oscillator
- CSW 50.28
- SLNO 52.70
About CSW CSW Industrials Inc. Common Stock
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.